View drug registration information details.
Items | Registration information |
ID | 2195 |
No | 2195 |
Brand Name | JENTIN MET |
Ingredients | SITAGLIPTIN PHOSPHATE MONOHYDRATE EQ.TO SITAGLIPTIN 50 MG, METFORMIN HCL 500 MG |
Dosage Form | FILM-COATED TABLETS |
Primary Packaging | ALU-BLISTER |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 2 X 7'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHEN TREATMENT WITH BOTH SITAGLIPTIN AND METFORMIN IS APPROPRIATE |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | ORANGISH COLOR, BICONVEX, ROUND SHAPED, FILM COATED TABLETS, ENGRAVED SEARLE ON ONE SIDE AND BREAKLINE ON OTHER SIDE |
Note | |
License Owner | POUNSAB PHARMA CO.,LTD |
Manufacturer | THE SEARLE COMPANY LIMITED |
Country | PAKISTAN |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 12 I 4867/19 |
FDD Registration Date | 19-Apr-2023 |
Expiry Date | 18-Apr-2026 |
Back to drug list
|